The effect of hyperbaric oxygen on apoptosis and proliferation in severe acute pancreatitis  by Koh, Shir Lin et al.
ORIGINAL ARTICLE
The effect of hyperbaric oxygen on apoptosis and proliferation in
severe acute pancreatitishpb_099 629..637
Shir Lin Koh, Joon Win Tan, Vijayaragavan Muralidharan & Christopher Christophi
Department of Surgery, University of Melbourne, Austin Health, Melbourne, Victoria, Australia
Abstract
Objectives: This paper investigates the significance of apoptosis in severe acute pancreatitis (SAP) and
the possible modulating effects of hyperbaric oxygen (HBO).
Methods: Wistar rats (250–350 g) were induced with SAP by biliopancreatic infusion of 4% sodium
taurocholate. Rats were randomized for HBO treatment. Pancreatic tissue was stained for apoptosis with
immunohistochemistry (anti-CASPASE-3 antibody and TUNEL), and histopathology haematoxylin and
eosin (H&E). Acini were stained for proliferation with an anti-KI67 antibody. ImageProPlus was used to
quantify apoptosis and proliferation in acinar cells. Statistical analysis was performed with two-
independent-sample t-test or non-parametric Mann–Whitney test.
Results: In normal acini there is a low rate of apoptosis (0.165  0.157%, 0.181  0.168%, 0.130 
0.298% in CASPASE-3, H&E and TUNEL, respectively) and proliferation (0.951  0.926%) (mean 
standard deviation [SD]). When compared with normal, apoptosis (CASPASE-3: 1.28  1.12%, P = 0.008;
2.40  3.04%, P = 0.101; 1.23  0.87%, P = 0.091; H&E: 0.47  0.36%, P = 0.051; 0.69  0.63%, P =
0.001; 0.68  0.28%, P = 0; TUNEL: 1.08  1.42%, P = 0; 1.96  1.87%, P = 0; 2.36  2.26%, P = 0)
and proliferation (1.96  1.89%, P = 0.187; 1.73  1.76%, P = 0.165; 1.36  1.40%, P = 0.571) were
increased on days 1, 2 and 3 post-induction, respectively. In comparison with the untreated controls, HBO
increased apoptosis on day 1 (CASPASE-3: 3.11  1.97%, P = 0.04; H&E: 0.97  0.76%, P = 0.005) and
day 2 (TUNEL: 3.61  3.05%, P = 0.034). Treatment with HBO increased proliferation (3.04  3.14%,
P = 0.519; 7.33  7.55%, P = 0.153) on days 2 and 3, respectively, compared with the untreated controls.
Conclusions: During SAP, acini apoptosis and proliferation were increased. Hyperbaric oxygen therapy
may improve the condition of SAP by promoting apoptosis and proliferation.
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Introduction
Acute pancreatitis (AP) has an annual incidence of 30–40 per
100 000 population.1 The majority of patients experience mild
attacks, which are self-limiting. Approximately 20–30% of
patients manifest the severe form of AP, which has an associated
mortality rate of approximately 30%.2 These patients develop
pancreatic necrosis, leading to sepsis, systemic inflammatory
response syndromes and multiple organ failure.3 Although the
mechanisms of acinar cell death are still poorly understood,
accumulating data now show that the type of cell death is a sig-
nificant determinant of the severity of disease.4–6 Both apoptosis
and cell necrosis have been observed as the mechanisms of cell
death in AP. Studies have shown that apoptosis of acinar cells
predominates in the mild form of AP, whereas necrosis is
associated with severe acute pancreatitis (SAP).7 The severity of
SAP appears to be favourably altered by switching cell
death from necrosis to apoptosis.8 In addition, animals pre-
induced with apoptosis showed a decrease in the severity of
pancreatitis.5
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Hyperbaric oxygen (HBO) therapy refers to the administration
of 100% oxygen at high pressures. This therapy promotes wound
healing by amplifying oxygen gradients along the periphery of
ischaemic wounds and promotes the oxygen-dependent collagen
matrix formation needed for angiogenesis.9–11 The administration
of HBO has been shown to be safe and the therapy plays a role in
improving patient outcomes.12 HBO therapy has been demon-
strated in our previous study of a rat model of SAP to improve
survival and decrease the severity of disease by reducing the extent
of necrosis.13 As well as improving the pancreatic microcircula-
tion,14 our study also showed that HBO therapy significantly
improved the macroscopic severity score and the level of amylase
and lipase in rat serum.13 The effect of HBO on apoptosis,
however, is undefined. This paper reports an observational study
on the changes in apoptosis and proliferation in SAP and the
effect of HBO therapy.
Materials and methods
Animal model of severe acute pancreatitis
Forty-four male albino Wistar rats (250–350 g) were housed pair-
wise in cages with free access to standard rat chow and water, on a
12-hour light/dark cycle. All experiments were conducted accord-
ing to the protocol of the Austin Health Animal Ethics Committee.
Rats were randomly assigned to a control group in which animals
underwent laparotomy and which was used as a baseline for
normal apoptosis and proliferation rates, and an intervention
group in which animals were induced with SAP and some were
randomly assigned for HBO treatment. The first dose was admin-
istered at 6 h post-induction of SAP and subsequent doses were
given twice daily thereafter. Surviving animals in each group were
killed at time-points of days 1, 2 and 3 post-induction of SAP.
There were at least four animals per study group (n = 7 normal
rats; n = 9, n = 8 and n = 4 SAP rats killed on days 1, 2 and 3,
respectively, and n = 5, n = 6 and n = 5 SAP rats treated with HBO
and killed on days 1, 2 and 3, respectively).
Induction of severe acute pancreatitis
Animals were fasted overnight prior to induction, with access to
water ad libitum. Animals were anaesthetized by intraperitoneal
injection of ketamine hydrochloride (66.7 mg/kg) mixed with
xylazine (6.7 mg/kg). Preoperative carprofen (5 mg/kg) and 5 ml
of 0.5% saline were given subcutaneously for pain relief and
hydration, respectively. Severe acute pancreatitis was induced
using a well-established method by retrograde infusion of
4% sodium taurocholate (Sigma-Aldrich [Pty] Ltd, Castle Hill,
Australia).14 Hyperaemia of the pancreas was visible during infu-
sion, confirming the induction of the disease. Animals were moni-
tored throughout by health assessment guidelines.
Hyperbaric oxygen therapy
A purpose-built animal chamber was used for HBO therapy
(Department of Surgery, Austin Health). Pressure was increased
steadily for 10 min to reach 153 kPa. The pressure was maintained
at 153 kPa for a treatment of 90 min, followed by a 15 min
depressurization.
Health assessment
Rats were scored on a health assessment twice daily in a blinded
manner. Animals were assessed using the animal health scoring
criteria and killed accordingly.15 Each health criteria is graded
between 0 and 2, where 0 represents normal and 2 represents
severe or complete. Scores of 0–4 equate to good health, 5–8 to
satisfactory, 9–13 to poor and 14–24 to very poor health. The
highest possible score is 24. If an animal scored 14, it would be
killed if no improvement was shown after 2 h of observation. The
mean of the scores for each day was calculated.
Blood and tissue collection and processing
At days 1, 2 and 3 post-induction of SAP, animals were anaesthe-
tized. Macroscopic scoring for the severity of the disease (Table 1)
and tissue collection was performed. The pancreas head was fixed
with 10% buffered formalin (Sigma Aldrich [Pty] Ltd). Samples
were processed and embedded in paraffin by the Department
of Anatomical Pathology, Austin Health. Tissues were sectioned
at 4 mm using a microtome (Leica Microsystems [Pty] Ltd,
Gladesville, Australia) and stained for acinar cell apoptosis and
proliferation activities.
Macroscopic scoring of the severity of severe acute
pancreatitis
Macroscopic severity of SAP was assessed using a validated system
previously used in other studies (Table 1).13,16 Each parameter rep-
resents a marker of pancreatitis and its progression, namely
ascites, pancreatic oedema, pancreatic necrosis, pancreatic haem-
orrhage and extra-pancreatic fat necrosis. The maximum possible
score is 15.
Histopathological staining
Tissue sections were stained with Mayer’s haematoxylin and eosin
(H&E). Sections were dewaxed in histolene and rehydrated in
ethanol. They were then stained in haematoxylin for 2 min, fol-
lowed by rinsing in Scott’s tap water and counter-staining in eosin
for 2 min. Sections were dehydrated with ethanol and histolene.
DePX (Crown Scientific [Pty] Ltd, Rowville, VIC) mounting
medium was applied to mount the slides. Images were taken at
40¥ magnification using the Nikon Coolscope digital microscope
(Nikon Corp., Tokyo, Japan).
Immunohistochemical staining
The quantification of apoptosis is commonly performed using
morphological staining of the tissues, H&E (Fig. 1). However, the
different stages of apoptosis may affect the detection level, espe-
cially when apoptotic cells do not appear to resemble a ‘typical’
cell undergoing apoptosis. Therefore, quantification of apoptosis
based on morphological assessment alone may not be sufficient.
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In this study, as well as H&E, we utilized immunohistochemistry,
using an anti-CASPASE-3 antibody (Fig. 2) and TUNEL (Fig. 3)
to detect apoptotic acini. For immunohistological assessment,
rabbit polyclonal anti-CASPASE-3 (Abcam Plc, Cambridge. UK)
and ApopTag plus peroxidase in situ apoptosis terminal deoxy-
nucleotidyl transferase dUTP nick-end labelling TUNEL kit
(Chemicon Australia Pty Ltd, Boronia, Australia) were used to
detect apoptotic cells. Mouse anti-rat KI67 MIB-5 clone (Dako
Cytomation, Botany, Australia) was used to detect proliferative
cells. Slides were dewaxed in histolene and rehydrated with
ethanol. Slides were washed in phosphate-buffered solution (PBS)
with 0.05% Tween20 (Biolab Aust. Ltd, Mulgrave, Australia).
Antigen retrieval was performed using citrate buffer (pH 6),
at 99 °C for 20 min. Non-specific binding sites were blocked
using 20% normal goat serum (Zymed; Invitrogen Australia Pty
Ltd, Mount Waverly, Australia) and incubated in a humidified
chamber at room temperature for 20 min. The rabbit polyclonal
anti-CASPASE-3 antibody (Abcam Plc) was prepared at 1 : 20
dilution to achieve 0.01 mg/ml antibody concentration. The
diluent used was 5% fetal calf serum in PBS. The slides were
incubated for 1 h at room temperature in a humidified chamber.
Negative control sections were incubated with diluent only.
Following that, endogenous peroxidases were blocked with 3%
hydrogen peroxide (Sigma-Aldrich [Pty] Ltd) for 30 min.
Table 1 Macroscopic scoring of the severity of severe acute pancreatitis
Variable Score Criteria
Ascites 0 Absent
1 Focal, limited to paravetebral gutters
2 Intermediate, surrounding small bowel loops
3 Massive, escaping out of the abdomen at laparotomy
Pancreatic oedema 0 Absent
1 Focal, limited to duodenal or splenic part, lobular structure not visible
2 Intermediate, limited to duodenal or splenic part, lobular structure visible.
3 Massive, involving the whole pancreas
Pancreatic necrosis 0 Absent
1 Focal, limited to either the duodenal or splenic part of pancreas
2 Intermediate, involving whole pancreas, non-coalescent
3 Massive, coalescent foci within the whole pancreas
Pancreatic haemorrhage 0 Absent
1 Focal, limited to either the duodenal or splenic part of pancreas
2 Intermediate, involving whole pancreas, non-coalescent
3 Massive, coalescent foci within the whole pancreas
Extra-pancreatic fat necrosis 0 Absent
1 Focal, <5 spots, non-coalescent
2 Intermediate, 5–15 spots, non-coalescent
3 Massive, >15 spots, or coalescent spots
Table 1 shows the assessment criteria of macroscopic scoring for the severity of severe acute pancreatitis. Each parameter represents a marker of
pancreatitis and its progression, namely ascites, pancreatic oedema, pancreatic necrosis, pancreatic haemorrhage and extra-pancreatic fat necrosis.
The maximum possible score is 1513,16
Figure 1 Immunohistochemistry performed using rabbit active
CASPASE-3 antibody with DAB+ and haematoxylin counterstain on
rat pancreas in: (A) normal, (B, D, F) severe acute pancreatitis (SAP),
and (C, E, G) SAP treated with hyperbaric oxygen (HBO) on days 1,
2 and 3 post-induction of SAP, respectively. Positive acinar cells for
apoptosis are stained brown (circles). Scale bar: 100 mm
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For detection of proliferative acinar cells, MIB5 mouse anti-rat
KI67 (Dako Cytomation) was used as the primary antibody, at a
dilution of 1 : 25 to achieve 0.0076 mg/ml concentration. The sec-
tions were incubated with the primary antibody for 3 h at room
temperature. Negative control sections were incubated with anti-
body diluent and peroxidase block was performed prior to the
normal goat serum block. The rest of the detection for both anti-
bodies was performed with the Dako Envision Plus kit (Dako
Cytomation) for active CASPASE-3 and KI67 respectively. Horse-
radish peroxidase-conjugated goat anti-rabbit or anti-mouse anti-
bodies were used and the slides were incubated for 30 min at room
temperature. Slides were incubated with DAB+ enzyme substrate
for 10 min. Slides were counter-stained with haematoxylin and
Scott’s tap water for 2 min each, and were rehydrated with
100 μm 
A
B
F G
D E
C
Figure 2 Histology staining with haematoxylin and eosin on rat pancreas. Positive acinar cells for apoptosis of various stages are determined
by their morphology (circles). Scale bar: 25 mm
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ethanol. The TUNEL kit was used according to the manufacturer’s
protocol with the Tdt enzyme diluted to 1 : 5.
Quantification of immunohistochemical and
histopathological staining
Images of stained sections were taken using a Nikon Coolscope
digital microscope. Random images of the pancreatic section were
taken at 20¥ or 40¥ magnifications, at regular intervals, until the
entire pancreas was covered. The images were analysed using
ImageProPlus Version 4.5 (Media Cybernetics Inc., Bethesda, MD,
USA). A grid of 20 squares was applied to every image. Six squares
were randomly pre-chosen as a template for analysis on each
image. Only cells that were clearly identified as acinar cells were
counted. Positively stained apoptotic acinar cells were identified
via immunohistochemical and histopathological stainings: (i)
CASPASE-3 cells appeared as brown staining in either the nucleus
or the cytoplasm (Fig. 2); (ii) H&E staining of the cells was iden-
tified via cell morphology (Fig. 1), and (iii) cells appeared green in
colour when stained with TUNEL kit (Fig. 3). KI67-positive cells
undergoing proliferation were identified as brown staining in the
nucleus (Fig. 4). The positive cells were counted in the regions
within six designated grid squares and a total of 1000–1500 cells
were counted for each sample.
Statistical analysis
Apoptosis and proliferation rates were measured as a percentage
of positively stained cells out of the total acinar cells in each
pancreatic head region. In each animal, the rate was defined by the
mean of the percentages (%) of positively stained cells of all
images standard deviation. All animals were grouped according
to study group and a mean percentage of the group was obtained.
Health assessment and macroscopic scores were also analysed. All
analyses were performed in a blinded manner. Normally dis-
tributed data were analysed using Student’s t-test or anova, as
appropriate. Data that were not normally distributed were analy-
sed with Mann–Whitney U-test. P-values <0.05 were considered
significant. Statistical methods were reviewed by the University of
Melbourne Statistical Consulting Centre.
Results
Apoptosis in SAP and the effects of HBO (Table 2)
The acinar lobule morphology was disrupted in SAP across all
time-points when compared with that of normal pancreas. The
acinar cells were also not as well organized in the pancreas of rats
with SAP compared with the normal pancreatic acini and the
apoptotic acinar cells were scattered heterogeneously throughout
the pancreatic tissue (Fig. 2). Positively stained cells were mainly
observed at the periphery of the pancreatic ducts (Fig. 2). Acinar
cells stained with all three methods showed a low baseline rate of
apoptosis in normal rat pancreas (0.16  0.16%, 0.18  0.17%,
0.13  0.30% for CASPASE-3 [Fig. 2A], H&E and TUNEL,
respectively).
When compared with the rate of apoptosis in normal acini,
apoptosis was increased in SAP on days 1, 2 and 3, respectively
(CASPASE-3: 1.28 1.12% [P = 0.008], 2.40 3.04% [P = 0.101],
1.23 0.87% [P = 0.091]; H&E: 0.47 0.36% [P = 0.051], 0.69
0.63% [P = 0.001], 0.68  0.28% [P = 0]; TUNEL: 1.08  1.42%
[P = 0], 1.96  1.87% [P = 0], 2.36  2.26% [P = 0]). Apoptosis
peaked on day 2 with CASPASE-3 and H&E, and on day 3 using
TUNEL staining. When compared with normal rats, HBO-treated
rats showed higher rates of apoptosis at all time-points. Therapy
with HBO also increased apoptosis on day 1 (CASPASE-3:
3.11  1.97%, 1.28  1.12% [P = 0.04]; H&E: 0.97  0.76%,
0.47  0.36% [P = 0.005]) and day 2 (TUNEL: 3.61  3.05%,
1.96  1.87% [P = 0.034]) compared with untreated rats.
Proliferation in acinar cells and the effects of HBO
(Table 3)
Proliferating cells express KI67, a nuclear antigen. Cell nucleus
positive for KI67 was stained dark brown (Fig. 4). From general
observation, the positively stained acinar cells were scarce and
heterogeneously distributed (Fig. 4). The normal rate of prolifer-
ating cells was found to be 0.951  0.926%. Severe acute pancre-
atitis increased the rate of proliferation (1.96  1.89%, 1.73 
1.76%, 1.36 1.40%; P > 0.05) on days 1, 2 and 3 post-induction
of SAP, respectively. Acinar cells in the HBO-treated groups on
days 1, 2 and 3 (1.11  1.03%, 3.04  3.14%, 7.33  7.55%,
respectively; P > 0.05) showed higher rates of proliferation com-
pared with acinar cells in the normal group. Rates of proliferation
were also compared between the SAP and HBO-treated groups.
On day 1, HBO therapy decreased the rate of proliferation. In
contrast, HBO increased the rate of proliferation at the later time-
points on days 2 and 3. Although the differences between the
treated and untreated groups were not found to be statistically
significant (P = 0.375, P = 0.519, P = 0.153 for days 1, 2 and 3,
respectively), there was increased proliferation in the HBO-
treated groups at the later endpoints.
Figure 3 Immunohistochemistry with in situ apoptosis terminal
deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) and
methyl green counterstain on rat pancreas. Positive acinar cells for
apoptosis are stained brown (circles). Scale bar: 25 mm
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Health assessment and macroscopic severity
scorings (Tables 1, 4 and 5)
Both the health assessment (post-induction until the animal
endpoints) and the macroscopic scoring (performed at the
endpoint laparotomy) were lower in the HBO-treated groups,
especially at the early time-points. However, the differences
between the groups did not render statistical significance (P >
0.05).
Discussion
Apoptosis is a programmed cell death involving the activation
of caspases, shrinkage of chromatin and formation of small
100 μm 
*
A
CB
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F G
E
Figure 4 Immunohistochemistry using mouse anti-rat KI67 antibody with DAB+ and haematoxylin counterstain on rat pancreas in: (A)
normal, (B, D, F) untreated severe acute pancreatitis (SAP), and (C, E, G) SAP treated with hyperbaric oxygen (HBO) on days 1, 2 and 3,
respectively. (A) Normal pancreas shows a baseline proliferation rate in rat acinar cells. Positive acinar cells for proliferation are stained brown
(circles) and blood vessels are marked with (*). Scale bar: 100 mm
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membrane-bound apoptotic bodies, which are then engulfed by
macrophages.6,17 Unlike necrosis, it does not compromise the
integrity of the cell membrane nor disturb the physiology of the
surrounding tissues.7,18 Previous studies have shown necrosis to
be associated with SAP, whereas milder forms of AP involve apo-
ptosis.4 Kaiser et al. (1995) observed a high level of pancreatic
necrosis and few apoptotic cells in SAP, but the reverse in milder
models of AP.7 Other studies have also shown that
Table 2 Quantification of apoptosis in acinar cells
Groups n Apoptosis, % P-value (normal
vs. all groups)
P-value (SAP
vs. SAP + HBO)
(a) CASPASE-3
Normal 7 0.17  0.16
SAP D1 8 1.28  1.12 0.008* 0.04*
SAP + HBO D1 5 3.11  1.97 0.028*
SAP D2 7 2.40  3.04 0.101 0.792
SAP + HBO D2 6 2.78  1.81 0.016*
SAP D3 4 1.23  0.87 0.091 0.197
SAP + HBO D3 5 2.07  0.90 0.008*
(b) H&E
Normal 7 0.18  0.17
SAP D1 8 0.47  0.36 0.051 0.005*
SAP + HBO D1 5 0.97  0.76 0*
SAP D2 7 0.69  0.63 0.001* 0.116
SAP + HBO D2 6 0.86  0.46 0*
SAP D3 4 0.68  0.28 0* 0.093
SAP + HBO D3 5 1.19  0.74 0*
(c) TUNEL
Normal 7 0.13  0.30
SAP D1 8 1.08  1.42 0* 0.07
SAP + HBO D1 5 1.49  1.33 0*
SAP D2 7 1.96  1.87 0* 0.034*
SAP + HBO D2 6 3.61  3.05 0*
SAP D3 4 2.36  2.26 0* 0.117
SAP + HBO D3 5 3.32  2.72 0*
Table 2 shows the mean percentage (%) of apoptosis in acini of normal, severe acute pancreatitis (SAP) and SAP treated with hyperbaric oxygen
(HBO) therapy rats. The quantification of apoptosis was performed by staining using the immunohistochemical (a) CASPASE-3 and (c) TUNEL, and
histological (b) haematoxylin and eosin methods. The rate of apoptosis is expressed as the mean of group  standard deviation (SD). Statistical
analysis was made between normal and all other groups, and between the SAP untreated and HBO-treated groups at all endpoints. Statistical
significance (P < 0.05) is indicated by (*)
Table 3 Proliferation in normal, severe acute pancreatitis and hyperbaric oxygen therapy-treated rat acini
Groups n Mean of
proliferation, %
Standard
deviation, %
P-values (normal
vs. SAP)
P-values (SAP
vs. SAP + HBO)
Normal 7 0.95 0.93
SAP day 1 9 1.96 1.89 0.187 0.375
SAP + HBO day 1 5 1.10 1.03 0.788
SAP day 2 8 1.73 1.76 0.165 0.519
SAP + HBO day 2 6 3.04 3.14 0.169
SAP day 3 4 1.36 1.40 0.571 0.153
SAP + HBO day 3 5 7.33 7.55 0.132
Table 3 shows the rate of proliferation (%) in normal, severe acute pancreatitis (SAP) and SAP treated with hyperbaric oxygen (HBO) acini stained with
immunohistochemistry using anti-KI67 antibody. The rate of proliferation was higher in SAP when compared with normal acini. HBO decreased the
rate of proliferation in SAP on day 1 and increased the rate of proliferation on days 2 and 3 post-induction of SAP. However, there was no statistical
significance between any groups (P > 0.05)
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pre-pancreatitis induction of apoptosis has a protective effect on
pancreatitis.17,18
Apoptosis is an energy-requiring process and thus it may not be
as efficient in a hypoxic environment such as SAP.4 During HBO
therapy, tissue oxygenation is increased to levels that are sufficient
to support tissues independent of haemoglobin, providing suffi-
cient oxygen for the cells to generate enough adenosine triphos-
phate (ATP) for apoptosis to occur. This reversal in hypoxia lasts
for a significant time following therapy.13,19 Hyperbaric oxygen
therapy has been shown in clinical studies to benefit patients with
SAP. Patients treated with HBO showed improvements according
to clinical, biochemical and radiological criteria of disease sever-
ity.12 Other experimental studies showed increased survival and
reduced necrosis as well as decreased severity of SAP.13,20–24
However, the exact mechanisms of improvement with HBO have
not been fully investigated.
In our study, the rates of apoptosis and proliferation were
elevated during SAP. Treatment with HBO further increased their
levels and shifted the peaks of apoptosis and proliferation to
earlier and later time-points, respectively. Although acinar cells
start regenerating at the early phase of injury,25 as shown in our
study, they are unable to regenerate over an extended period of
time. With HBO, there was sustained proliferation, resembling
that of the milder AP model.26 Therefore, other than promoting
apoptosis, the beneficial effects of HBO therapy12,13 may also be
associated with increased proliferation following apoptosis.27
As successive HBO treatments were administered over time, the
need for apoptosis was decreased, probably as a result of the
improved condition. However, decreased apoptosis at the later
time-points in the treated groups may also indicate the clearance
of apoptotic cells by macrophages.17 In this study, we have also
shown that HBO increased apoptosis in all cells, whether or not
they were injured, as there was continuing apoptosis, albeit
decreased, at the later time-points despite the increase in survival
and an improvement in the condition of SAP shown in our pre-
vious study.13 Although we propose that one of the mechanisms by
which HBO therapy improves survival and disease outcome4,6,7,13
concerns the promotion of apoptosis, the relationship between
apoptosis and necrosis remains unclear. Further studies are
required to determine if the improvements brought about by
HBO therapy are associated with a diversion of necrosis to apop-
tosis, or whether they reflect the induction of apoptosis itself.
Regardless of which is the case, both possible explanations for our
findings suggest that successive administration of HBO therapy, at
the early stages of SAP, improves the disease condition,13,14 as
supported by the lower macroscopic severity and health assess-
ment scores in the treated group, although the differences between
the groups did not render statistical significance.
Table 4 Health assessment scores post-induction of severe acute pancreatitis
Time-points Groups/P-value
(SAP vs. SAP + HBO)
Health assessment scores (mean  SD)
Day 0 Day 1 Day 2 Day 3
Day 1 SAP 5.17  1.33 6.45  1.96
SAP + HBO 4.8  1.30 5.6  2.46
P-value 0.657 0.517
Day 2 SAP 5  1.9 5.57  1.31 6.29  2.56
SAP + HBO 5.5  1.05 5.01  1.24 5.5  1.38
P-value 0.585 0.449 0.517
Day 3 SAP 4.7  1.41 5  1.47 4.96  2.33 5  1.41
SAP + HBO 4.7  0.84 5.55  0.87 5.17  1.5 4.47  2.22
P-value 0.432 0.505 0.872 0.690
Table 4 shows the health assessment scores of rats with severe acute pancreatitis (SAP) untreated and treated with hyperbaric oxygen (HBO)
post-induction on the day of procedure (day 0), until days 1, 2 and 3 post-induction. The health assessment scores are expressed as mean of each
group  standard deviation (SD). The differences between the untreated and HBO-treated groups were not statistically significant (P > 0.05)
Table 5 Macroscopic severity scores at endpoints
Groups and P-value (SAP
vs. SAP + HBO)/endpoints
Macroscopic severity scores (mean  SD)
Day 1 Day 2 Day 3
SAP 9.13  3.48 10.43  3.60 8  3.16
SAP + HBO 7.4  2.70 10.17  1.84 10  2
P-value 0.368 0.875 0.283
Table 5 shows the macroscopic severity scores of rats with severe acute pancreatitis (SAP) untreated and treated with hyperbaric oxygen (HBO) at
their endpoint laparotomy on days 1, 2 and 3 post-induction. The macroscopic scores for the untreated and treated rats on days 1, 2 and 3,
respectively, are expressed as mean of group  standard deviation (SD). The differences between the untreated and treated groups at all the
endpoints were not statistically significant (P > 0.05)
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As we endeavour to mimic the severe form of AP in our model,
there is a high mortality rate and a high variability in the disease
manifestation. As a result, extensive time and resources are
necessary to generate an adequate sample size per study group.
Although there were a few limitations to this study, we have shown
increased levels of apoptosis and proliferation in SAP, and have
demonstrated that HBO may prove beneficial in improving the
disease outcome by modulating apoptosis and proliferation. Our
data also suggest the possible role of the CASPASE-3 dependent
cell death pathway at the early stage of SAP. Potential therapeutic
intervention targeting this system may select the preferred cell
death pathway in order to improve outcomes in this disease. For
future studies, possible mechanisms of cell death should be
further investigated.
Acknowledgements
We would like to thank Dr Cris Cuthbertson and Cathy Malcontenti-Wilson for
their contributions and technical support.
Conflicts of interest
None declared.
References
1. Felderbauer P, Muller C, Bulut K, Belyaev O, Schmitz F, Uhl W et al.
(2005) Pathophysiology and treatment of acute pancreatitis: new thera-
peutic targets – a ray of hope? Basic Clin Pharmacol Toxicol 97:342–350.
2. Perez A, Whang EE, Brooks DC, Moore FD Jr, Hughes MD, Sica GT et al.
(2002) Is severity of necrotizing pancreatitis increased in extended necro-
sis and infected necrosis? Pancreas 25:229–233.
3. Lai PB. (2001) Local renin-angiotensin system in the pancreas: the sig-
nificance in acute pancreatitis. JOP 2:13–15.
4. Bhatia M. (2004) Apoptosis versus necrosis in acute pancreatitis. Am J
Physiol Gastrointest Liver Physiol 286:G189–G196.
5. Saluja A, Hofbauer B, Yamaguchi Y, Yamanaka K, Steer M. (1996) Induc-
tion of apoptosis reduces the severity of caerulein-induced pancreatitis in
mice. Biochem Biophys Res Commun 220:875–878.
6. Bhatia M. (2004) Apoptosis of pancreatic acinar cells in acute pancreati-
tis: is it good or bad? J Cell Mol Med 8:402–409.
7. Kaiser AM, Saluja AK, Sengupta A, Saluja M, Steer ML. (1995) Relation-
ship between severity, necrosis, and apoptosis in five models of experi-
mental acute pancreatitis. Am J Physiol 269 (5 Pt 1):C1295–C1304.
8. Gukovskaya AS, Pandol SJ. (2004) Cell death pathways in pancreatitis
and pancreatic cancer. Pancreatology 4:567–586.
9. Gill AL, Bell CN. (2004) Hyperbaric oxygen: its uses, mechanisms of
action and outcomes. QJM 97:385–395.
10. Hunt TK. (1988) The physiology of wound healing. Ann Emerg Med
17:1265–1273.
11. Knighton DR, Silver IA, Hunt TK. (1981) Regulation of wound-healing
angiogenesis-effect of oxygen gradients and inspired oxygen concentra-
tion. Surgery 90:262–270.
12. Christophi C, Millar I, Nikfarjam M, Muralidharan V, Malcontenti-Wilson C.
(2007) Hyperbaric oxygen therapy for severe acute pancreatitis. J Gas-
troenterol Hepatol 22:2042–2046.
13. Nikfarjam M, Cuthbertson CM, Malcontenti-Wilson C, Muralidharan V,
Millar I, Christophi C. (2007) Hyperbaric oxygen therapy reduces severity
and improves survival in severe acute pancreatitis. J Gastrointest Surg
11:1008–1015.
14. Cuthbertson CM, Su KH, Muralidharan V, Millar I, Malcontenti-Wilson C,
Christophi C. (2008) Hyperbaric oxygen improves capillary morphology in
severe acute pancreatitis. Pancreas 36:70–75.
15. Laboratory Animal Science Association Working Party. (1990) The
assessment and control of the severity of scientific procedures on labo-
ratory animals. Lab Anim 24:97–130.
16. Schulz HU, Hoenl H, Schrader T, Kropf S, Halangk W, Ochmann C et al.
(2001) Randomized, placebo-controlled trial of lazaroid effects on severe
acute pancreatitis in rats. Crit Care Med 29:861–869.
17. Cao Y, Adhikari S, Clement MV, Wallig M, Bhatia M. (2007) Induction of
apoptosis by crambene protects mice against acute pancreatitis via
anti-inflammatory pathways. Am J Pathol 170:1521–1534.
18. Bhatia M, Wallig MA, Hofbauer B, Lee HS, Frossard JL, Steer ML et al.
(1998) Induction of apoptosis in pancreatic acinar cells reduces the
severity of acute pancreatitis. Biochem Biophys Res Commun 246:476–
483.
19. Grim PS, Gottlieb LJ, Boddie A, Batson E. (1990) Hyperbaric oxygen
therapy. JAMA 263:2216–2220.
20. Formela LJ, Galloway SW, Kingsnorth AN. (1995) Inflammatory mediators
in acute pancreatitis. Br J Surg 82:6–13.
21. Browne GW, Pitchumoni CS. (2006) Pathophysiology of pulmonary
complications of acute pancreatitis. World J Gastroenterol 12:7087–
7096.
22. Bhatia M, Wong FL, Cao Y, Lau HY, Huang J, Puneet P et al. (2005)
Pathophysiology of acute pancreatitis. Pancreatology 5:132–144.
23. Yasar M, Yildiz S, Mas R, Dundar K, Yildirim A, Korkmaz A et al. (2003)
The effect of hyperbaric oxygen treatment on oxidative stress in experi-
mental acute necrotizing pancreatitis. Physiol Res 52:111–116.
24. Balkan A, Balkan M, Yasar M, Korkmaz A, Erdem O, Kilic S et al. (2006)
Pulmonary protective effects of hyberbaric oxygen and N-acetylcysteine
treatment in necrotizing pancreatitis. Physiol Res 55:25–31.
25. Ledda-Columbano GM, Perra A, Pibiri M, Molotzu F, Columbano A.
(2005) Induction of pancreatic acinar cell proliferation by thyroid
hormone. J Endocrinol 185:393–399.
26. Elsasser HP, Adler G, Kern HF. (1986) Time course and cellular source of
pancreatic regeneration following acute pancreatitis in the rat. Pancreas
1:421–429.
27. Abe K, Watanabe S. (1995) Apoptosis of mouse pancreatic acinar cells
after duct ligation. Arch Histol Cytol 58:221–229.
HPB 637
HPB 2009, 11, 629–637 © 2009 International Hepato-Pancreato-Biliary Association
